Total Payments
$673.36
2024 Payments
$203.62
Companies
6
Transactions
44
Medicare Patients
656
Medicare Billing
$11,353
Payment Breakdown by Category
Food & Beverage$673.36 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $673.36 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $437.17 | 18 | $0 (2024) |
| Corcept Therapeutics | $102.99 | 6 | $0 (2024) |
| Genentech USA, Inc. | $55.39 | 16 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $50.35 | 2 | $0 (2024) |
| Lilly USA, LLC | $14.01 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.45 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203.62 | 9 | Corcept Therapeutics ($84.60) |
| 2023 | $141.06 | 6 | ABBVIE INC. ($127.61) |
| 2022 | $193.47 | 9 | ABBVIE INC. ($175.08) |
| 2021 | $135.21 | 20 | AbbVie Inc. ($65.81) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Endocrinology | ||||||
| 07/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Endocrinology | ||||||
| 06/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Endocrinology | ||||||
| 05/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Endocrinology | ||||||
| 04/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: DIABETES | ||||||
| 05/02/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: VIROLOGY | ||||||
| 02/02/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: VIROLOGY | ||||||
| 09/07/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: VIROLOGY | ||||||
| 09/01/2022 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Endocrinology | ||||||
| 08/11/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: VIROLOGY | ||||||
| 04/19/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: VIROLOGY | ||||||
| 02/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: VIROLOGY | ||||||
| 02/12/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: VIROLOGY | ||||||
| 01/05/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 136 | 187 | $7,212 | $2,486 |
| 2022 | 7 | 168 | 209 | $8,460 | $3,204 |
| 2021 | 7 | 200 | 237 | $9,935 | $3,184 |
| 2020 | 7 | 152 | 193 | $7,842 | $2,479 |
Total Patients
656
Total Services
826
Medicare Billing
$11,353
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 28 | 58 | $1,160 | $940.76 | 81.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 37 | 40 | $1,400 | $648.00 | 46.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 18 | 25 | $1,625 | $258.75 | 15.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 12 | 14 | $882.00 | $230.44 | 26.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 18 | 25 | $875.00 | $190.25 | 21.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 12 | 14 | $1,050 | $183.68 | 17.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 11 | 11 | $220.00 | $34.21 | 15.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 26 | 49 | $980.00 | $802.20 | 81.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 42 | 42 | $1,470 | $686.46 | 46.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 19 | 20 | $1,000 | $664.18 | 66.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 26 | 34 | $2,210 | $354.06 | 16.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 28 | 35 | $1,225 | $268.11 | 21.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 13 | 15 | $945.00 | $248.26 | 26.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 14 | 14 | $630.00 | $180.65 | 28.7% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 62 | 66 | $2,310 | $1,091 | 47.2% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 24 | 47 | $940.00 | $777.85 | 82.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 33 | 37 | $2,405 | $390.72 | 16.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 19 | 20 | $1,260 | $336.00 | 26.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 19 | 21 | $1,575 | $281.19 | 17.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 32 | 35 | $1,225 | $271.95 | 22.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 11 | 11 | $220.00 | $34.87 | 15.9% |
| 87804 | Detection test for influenza virus | Office | 2020 | 22 | 49 | $980.00 | $796.76 | 81.3% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 32 | 35 | $1,225 | $570.63 | 46.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 28 | 33 | $2,145 | $344.70 | 16.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 18 | 19 | $1,197 | $316.82 | 26.5% |
About Roger Strunk
Roger Strunk is a Nurse Practitioner healthcare provider based in Hazard, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2017. The National Provider Identifier (NPI) number assigned to this provider is 1629513239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roger Strunk has received a total of $673.36 in payments from pharmaceutical and medical device companies, with $203.62 received in 2024. These payments were reported across 44 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($673.36).
As a Medicare-enrolled provider, Strunk has provided services to 656 Medicare beneficiaries, totaling 826 services with total Medicare billing of $11,353. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Hazard, KY
- Active Since 01/05/2017
- Last Updated 01/05/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629513239
Products in Payments
- MAVYRET (Drug) $209.25
- QULIPTA (Drug) $134.33
- Korlym (Drug) $102.99
- UBRELVY (Drug) $58.81
- Xofluza (Drug) $55.39
- BREZTRI (Drug) $36.83
- VRAYLAR (Drug) $34.78
- TRULICITY (Drug) $14.01
- FARXIGA (Drug) $13.52
- JARDIANCE (Drug) $13.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Hazard
Lori Akers, Aprn, APRN
Nurse Practitioner — Payments: $4,020
Nurse Practitioner $4,020
Jessica Lemaster, Aprn, APRN
Nurse Practitioner — Payments: $2,454
Nurse Practitioner $2,454
Ms. Kaitlin Watts, Aprn, APRN
Nurse Practitioner — Payments: $2,266
Nurse Practitioner $2,266
Ms. Sandra Krasnopolsky, Msn,Np-C, MSN,NP-C
Nurse Practitioner — Payments: $2,159
Nurse Practitioner $2,159
Ashley Elswick, Aprn, APRN
Nurse Practitioner — Payments: $1,902
Nurse Practitioner $1,902
Kristi Watts, Aprn, APRN
Nurse Practitioner — Payments: $1,247
Nurse Practitioner $1,247